Literature DB >> 11369587

Endothelin-1 mediates prostaglandin F(2alpha)-induced luteal regression in the ewe.

S T Hinckley1, R A Milvae.   

Abstract

A diversified series of experiments was conducted to determine the potential role of endothelin-1 (ET-1) in ovine luteal function. Endothelin-1 inhibited basal and LH-stimulated progesterone production by dispersed ovine luteal cells during a 2-h incubation. This inhibition was removed when cells were preincubated with cyclo-D-Asp-Pro-D-Val-Leu-D-Trp (BQ123), a highly specific endothelin ET(A) receptor antagonist. Administration of a luteolytic dose of prostaglandin F(2alpha) (PGF(2alpha)) rapidly stimulated gene expression for ET-1 in ovine corpora lutea (CL) collected at midcycle. Intraluteal administration of a single dose of BQ123 to ewes on Day 8 or 9 of the estrous cycle mitigated the luteolytic effect of PGF(2alpha). Intramuscular administration of 100 microg ET-1 to ewes at midcycle reduced plasma progesterone concentrations for the remainder of the estrous cycle. Following pretreatment with a subluteolytic dose of PGF(2alpha), i.m. administration of 100 microg ET-1 caused a rapid decline in plasma progesterone and shortened the length of the estrous cycle. These data complement and extend previously published reports in the bovine CL and are the strongest evidence presented to date in support of a role for ET-1 in PGF(2alpha)-mediated luteal function in domestic ruminants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369587     DOI: 10.1095/biolreprod64.6.1619

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  10 in total

1.  Endothelin B receptor is not required but necessary for finite regulation of ovulation.

Authors:  Jongki Cho; Heyyoung Kim; Dong-Wook Kang; Masashi Yanagisawa; CheMyong Ko
Journal:  Life Sci       Date:  2012-03-03       Impact factor: 5.037

2.  Endothelin type A receptor (ETA) expression is regulated by HOXA10 in human endometrial stromal cells.

Authors:  Ivan A Penna; Amanda N Kallen; Hugh S Taylor
Journal:  Reprod Sci       Date:  2010-05       Impact factor: 3.060

3.  The expression of angiotensin and endothelin system members in bovine corpus luteum during estrous cycle and pregnancy.

Authors:  Bajram Berisha; Dieter Schams; Akio Miyamoto
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

4.  Decreased cholesterol uptake and increased liver x receptor-mediated cholesterol efflux pathways during prostaglandin F2 alpha-induced and spontaneous luteolysis in sheep.

Authors:  Nickie L Seto; Randy L Bogan
Journal:  Biol Reprod       Date:  2015-04-16       Impact factor: 4.285

Review 5.  Endothelin 2: a key player in ovulation and fertility.

Authors:  CheMyong J Ko; Yoon Min Cho; Eugene Ham; Joseph A Cacioppo; Chan Jin Park
Journal:  Reproduction       Date:  2022-03-05       Impact factor: 3.906

6.  Adrenomedullin in rat follicles and corpora lutea: expression, functions and interaction with endothelin-1.

Authors:  Lei Li; Wai-Sum O; Fai Tang
Journal:  Reprod Biol Endocrinol       Date:  2011-08-09       Impact factor: 5.211

7.  Loss of function of endothelin-2 leads to reduced ovulation and CL formation.

Authors:  Joseph A Cacioppo; Sang Wook Oh; Hey-young Kim; Jongki Cho; Po-Ching Patrick Lin; Masashi Yanagisawa; CheMyong Ko
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

Review 8.  Microvascular endothelial cells of the corpus luteum.

Authors:  John S Davis; Bo R Rueda; Katherina Spanel-Borowski
Journal:  Reprod Biol Endocrinol       Date:  2003-11-10       Impact factor: 5.211

Review 9.  Regulation of intraluteal production of prostaglandins.

Authors:  Milo C Wiltbank; Joseph S Ottobre
Journal:  Reprod Biol Endocrinol       Date:  2003-11-10       Impact factor: 5.211

10.  Downregulation of lymphatic vessel formation factors in PGF2α-induced luteolysis in the cow.

Authors:  Akane Nitta; Koumei Shirasuna; Sayo Nibuno; Heinrich Bollwein; Takashi Shimizu; Akio Miyamoto
Journal:  J Reprod Dev       Date:  2013-03-25       Impact factor: 2.214

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.